Nano-Robot antibodies enter first human drug trial

First human drug trial of nanorobot antibodies to fight cancer

Scientists in Israel created the first nanorobot antibodies that are designed to fight cancer. Soon, the first human trials for the nano-robots are set to begin. This will test the effectiveness of the antibodies. These antibodies are also special in that they can be programmed to determine whether the cells around tumors are \”good\” or \”bad.\”

Trials are currently taking place in Australia. If all goes well, the nanorobot antibodies can fight tumor-helping cells while also increasing the ability of cells to inhibit the growth of cancerous cells. The antibodies were created by Professor Yanay Ofran, and they are based off of human and animal antibody.

Ofran explains that the goal of these nanorobot antibodies is unlocking the full potential antibodies have to offer. The use of antibodies for medicine is only a fraction of their capabilities. Since then, finding a method to maximize their capabilities has been an ongoing goal.


Nano-robot antibodies that fight cancer enter first human drug trial